Literature DB >> 19435793

Urokinase plasminogen activator receptor-deficient mice demonstrate reduced hyperoxia-induced lung injury.

Marieke A D van Zoelen1, Sandrine Florquin, Regina de Beer, Jennie M Pater, Marleen I Verstege, Joost C M Meijers, Tom van der Poll.   

Abstract

Patients with respiratory failure often require supplemental oxygen therapy and mechanical ventilation. Although both supportive measures are necessary to guarantee adequate oxygen uptake, they can also cause or worsen lung inflammation and injury. Hyperoxia-induced lung injury is characterized by neutrophil infiltration into the lungs. The urokinase plasminogen activator receptor (uPAR) has been deemed important for leukocyte trafficking. To determine the expression and function of neutrophil uPAR during hyperoxia-induced lung injury, uPAR expression was determined on pulmonary neutrophils of mice exposed to hyperoxia. Hyperoxia exposure (O2>80%) for 4 days elicited a pulmonary inflammatory response as reflected by a profound rise in the number of neutrophils that were recovered from bronchoalveolar lavage fluid and lung cell suspensions, as well as increased bronchoalveolar keratinocyte-derived chemokine, interleukin-6, total protein, and alkaline phosphatase levels. In addition, hyperoxia induced the migration of uPAR-positive granulocytes into lungs from wild-type mice compared with healthy control mice (exposed to room air). uPAR deficiency was associated with diminished neutrophil influx into both lung tissues and bronchoalveolar spaces, which was accompanied by a strong reduction in lung injury. Furthermore, in uPAR(-/-) mice, activation of coagulation was diminished. These data suggest that uPAR plays a detrimental role in hyperoxia-induced lung injury and that uPAR deficiency is associated with diminished neutrophil influx into both lung tissues and bronchoalveolar spaces, accompanied by decreased pulmonary injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435793      PMCID: PMC2684183          DOI: 10.2353/ajpath.2009.080914

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome.

Authors:  A Günther; P Mosavi; S Heinemann; C Ruppert; H Muth; P Markart; F Grimminger; D Walmrath; B Temmesfeld-Wollbrück; W Seeger
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  CD11/CD18-dependent and -independent neutrophil emigration in the lungs: how do neutrophils know which route to take?

Authors:  C M Doerschuk; S Tasaka; Q Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

Review 3.  Acute respiratory distress syndrome.

Authors:  Susannah K Leaver; Timothy W Evans
Journal:  BMJ       Date:  2007-08-25

4.  Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection.

Authors:  M R Gyetko; S Sud; T Kendall; J A Fuller; M W Newstead; T J Standiford
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

5.  Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA.

Authors:  M R Gyetko; S Sud; J Sonstein; T Polak; A Sud; J L Curtis
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

6.  Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice.

Authors:  J C Leemans; N P Juffermans; S Florquin; N van Rooijen; M J Vervoordeldonk; A Verbon; S J van Deventer; T van der Poll
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

Review 7.  Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature.

Authors:  J G Wagner; R A Roth
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

8.  Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats.

Authors:  R L Auten; R M Richardson; J R White; S N Mason; M A Vozzelli; M H Whorton
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

9.  Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats.

Authors:  H Deng; S N Mason; R L Auten
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

Review 10.  Hyperoxia and lung disease.

Authors:  C R Carvalho; G de Paula Pinto Schettino; B Maranhão; E P Bethlem
Journal:  Curr Opin Pulm Med       Date:  1998-09       Impact factor: 3.155

View more
  4 in total

1.  Effect of insulin-like growth factor blockade on hyperoxia-induced lung injury.

Authors:  Tae-Hyung Kim; Yu-Hua Chow; Sean E Gill; Lynn M Schnapp
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-05       Impact factor: 6.914

2.  Mitofusin-2 regulates leukocyte adhesion and β2 integrin activation.

Authors:  Wei Liu; Alan Y Hsu; Yueyang Wang; Tao Lin; Hao Sun; Joel S Pachter; Alex Groisman; Matthew Imperioli; Fernanda Wajnsztajn Yungher; Liang Hu; Penghua Wang; Qing Deng; Zhichao Fan
Journal:  J Leukoc Biol       Date:  2021-09-08       Impact factor: 4.962

3.  AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-β-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation.

Authors:  Arie J Hoogendijk; Sandra S Pinhanços; Tom van der Poll; Catharina W Wieland
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

4.  The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils.

Authors:  Gang Liu; Yanping Yang; Shanzhong Yang; Sami Banerjee; Andressa De Freitas; Arnaud Friggeri; Kasey I Davis; Edward Abraham
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.